These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 37351760

  • 21. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
    Rebelo JFD, Costa JM, Junqueira FD, Fonseca AO, de Almeida ABABS, Moraes AB, Vieira Neto L.
    Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
    [Abstract] [Full Text] [Related]

  • 22. Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.
    Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P.
    J Clin Med; 2021 Nov 25; 10(23):. PubMed ID: 34884211
    [Abstract] [Full Text] [Related]

  • 23. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H, Kranz S, Morell SM, Altieri B, Kroiss M, Detomas M, Fassnacht M, Deutschbein T.
    Front Endocrinol (Lausanne); 2023 Nov 25; 14():1123132. PubMed ID: 37223045
    [Abstract] [Full Text] [Related]

  • 24. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.
    J Clin Endocrinol Metab; 1999 Mar 25; 84(3):1022-7. PubMed ID: 10084590
    [Abstract] [Full Text] [Related]

  • 25. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J, Kjellman M, Wahrenberg H, Falhammar H.
    Endocrine; 2017 Nov 25; 58(2):267-275. PubMed ID: 28887710
    [Abstract] [Full Text] [Related]

  • 26. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May 25; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 27. Relationship Between Dexamethasone Suppression Test Cortisol Level >0.9 μg/dL and Depression and Quality of Life in Adrenal Incidentalomas: A Single Center Observational Case-Control Study.
    Güneş M, Güneş E, Kaya Mİ, Küçükelyas HD, Barut H, Öner S.
    Endocr Pract; 2024 Aug 25; 30(8):710-717. PubMed ID: 38729569
    [Abstract] [Full Text] [Related]

  • 28. Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas.
    Maser-Gluth C, Reincke M, Allolio B, Schulze E.
    Eur J Clin Invest; 2000 Dec 25; 30 Suppl 3():83-6. PubMed ID: 11281375
    [Abstract] [Full Text] [Related]

  • 29. Impaired Cognitive Function in Patients With Autonomous Cortisol Secretion in Adrenal Incidentalomas.
    Liu MS, Tian ZY, Zhang Z, Yang F, Lou Y, Wang YJ, Zeng YJ, Zhang ZW, Zhu DL, Li P.
    J Clin Endocrinol Metab; 2023 Feb 15; 108(3):633-641. PubMed ID: 36263685
    [Abstract] [Full Text] [Related]

  • 30. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
    Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP.
    J Clin Endocrinol Metab; 2014 Aug 15; 99(8):2754-62. PubMed ID: 24712565
    [Abstract] [Full Text] [Related]

  • 31. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
    Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, Nekić AB, Debono M, Lardo P, Ceccato F, Petramala L, Prete A, Chiodini I, Ivović M, Pazaitou-Panayiotou K, Alexandraki KI, Hanzu FA, Loli P, Yener S, Langton K, Spyroglou A, Kocjan T, Zacharieva S, Valdés N, Ambroziak U, Suzuki M, Detomas M, Puglisi S, Tucci L, Delivanis DA, Margaritopoulos D, Dusek T, Maggio R, Scaroni C, Concistrè A, Ronchi CL, Altieri B, Mosconi C, Diamantopoulos A, Iñiguez-Ariza NM, Vicennati V, Pia A, Kroiss M, Kaltsas G, Chrisoulidou A, Marina LV, Morelli V, Arlt W, Letizia C, Boscaro M, Stigliano A, Kastelan D, Tsagarakis S, Athimulam S, Pagotto U, Maeder U, Falhammar H, Newell-Price J, Terzolo M, Fassnacht M.
    Lancet Diabetes Endocrinol; 2022 Jul 15; 10(7):499-508. PubMed ID: 35533704
    [Abstract] [Full Text] [Related]

  • 32. Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: A review.
    Araujo-Castro M.
    Clin Endocrinol (Oxf); 2022 Dec 15; 97(6):693-701. PubMed ID: 35451056
    [Abstract] [Full Text] [Related]

  • 33. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G, Allasino B, Bovio S, Saba L, Ardito A, Angeli A, Terzolo M.
    J Endocrinol Invest; 2011 Jan 15; 34(1):e1-5. PubMed ID: 20634637
    [Abstract] [Full Text] [Related]

  • 34. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
    Rodrigues MO, Moraes AB, de Paula MP, Pereira VA, Leão ATT, Vieira Neto L.
    J Endocrinol Invest; 2021 Nov 15; 44(11):2455-2463. PubMed ID: 33788166
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
    Ueland GÅ, Grinde T, Methlie P, Kelp O, Løvås K, Husebye ES.
    Endocr Connect; 2020 Oct 15; 9(10):963-970. PubMed ID: 33032259
    [Abstract] [Full Text] [Related]

  • 36. The Quantitative Relationship Between Autonomous Cortisol Secretion, Dysglycemia and the Metabolic Syndrome.
    Bleier J, Shlomai G, Fishman B, Dotan Z, Rosenzweig B, Tirosh A.
    Endocr Pract; 2020 Sep 15; 26(9):974-982. PubMed ID: 33471702
    [Abstract] [Full Text] [Related]

  • 37. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE.
    J Endocrinol Invest; 2019 Dec 15; 42(12):1435-1442. PubMed ID: 31456173
    [Abstract] [Full Text] [Related]

  • 38. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
    Arruda M, Mello Ribeiro Cavalari E, Pessoa de Paula M, Fernandes Cordeiro de Morais F, Furtado Bilro G, Alves Coelho MC, de Oliveira E Silva de Morais NA, Choeri D, Moraes A, Vieira Neto L.
    J Hum Hypertens; 2017 Dec 15; 32(1):3-11. PubMed ID: 29176595
    [Abstract] [Full Text] [Related]

  • 39. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Pelsma I, Marina L, Lorenz K, Bancos I, Arlt W, Dekkers OM.
    Eur J Endocrinol; 2023 Jul 20; 189(1):G1-G42. PubMed ID: 37318239
    [Abstract] [Full Text] [Related]

  • 40. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.
    Yener S, Baris M, Peker A, Demir O, Ozgen B, Secil M.
    Clin Endocrinol (Oxf); 2017 Nov 20; 87(5):425-432. PubMed ID: 28656620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.